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Abstract
Caroli disease and Caroli syndrome are two rare congenital diseases of the intrahepatic bile
ducts. Caroli syndrome is characterized by the saccular dilatation of intrahepatic bile ducts
associated with congenital hepatic fibrosis. It is rarely diagnosed in childhood. We hereby
describe a case of Caroli syndrome in a young Tanzanian female who had abdominal pain and
distension since childhood. Her history suggested the presence of portal hypertension possibly
from congenital hepatic fibrosis. The diagnosis was reached based on ultrasound, computed
tomography (CT) scan of the abdomen, and magnetic resonance
cholangiopancreatography (MRCP).
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Introduction
Caroli disease refers to biliary ductular ectasia without any apparent hepatic abnormalities
while Caroli syndrome is the more common variant in which biliary ectasia is associated with
congenital fibrosis of the liver [1-2]. Congenital hepatic fibrosis refers to unique congenital liver
histology characterized by bland portal fibrosis, hyperproliferation of interlobular bile ducts
within the portal areas with variable shapes and sizes of bile ducts, and preservation of normal
lobular architecture [1-3]. Caroli syndrome is a developmental anomaly and there are many
theories explaining its pathogenesis. The most acceptable theory is related to ductal plane
malformation at different levels of the intrahepatic biliary tree [4]. This condition results from
an embryonic derangement of the bile ducts. As major bile ducts are affected, the result is
Caroli disease; whereas, abnormality affecting small ducts results in congenital hepatic
fibrosis.
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Case Presentation
A 28-year-old Tanzanian lady presented with complaints of intermittent right upper quadrant
abdominal discomfort and a huge swelling in the left upper abdomen since childhood. She is
the fourth born of six siblings who are healthy. Her mother had noted a left-sided firm
abdominal mass since childhood. Past medical history was significant for vomiting blood at the
age of two years. At the age of 16 years, she was diagnosed to have anemia and had received
transfusion. She denied history of recurrent fevers.
On examination, she was found to be lean, moderately pale and non-icteric. The liver was not
palpable. The spleen was palpable to the mid-pelvis, 20 cm from the left coastal margin mid
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clavicular line. Other physical signs were unremarkable. Laboratory investigations
showed white blood cell count of 8.7 x 103 per microliter of blood, hemoglobin 9 g/dl, mean
corpuscular hemoglobin (MCH) 21.4 pg per cell and platelets count of 36,000 per microliter of
blood. Liver function panel did not reveal any abnormality. Prothrombin time was 11 secs,
international normalized ratio (INR) 1, and activated partial thromboplastin time (aPTT) 31
seconds. Peripheral blood smear revealed microcytic/hypochromic picture. Erythrocyte
sedimentation rate (ESR) was 5 mm/hr and C-reactive protein (CRP) was 1 mg/L.
Computed tomography (CT) scan of the abdomen showed a normal liver size with no
parenchymal lesion. Intra hepatic biliary duct (IHBD) was grossly dilated and cystic (Figure 1).
The common bile duct (CBD) was not dilated. The gallbladder was shrunken with increased wall
thickness; the portal vein was dilated. There were multiple vascular collaterals at porta hepatis.
The splenic vein was dilated to 15 mm. The spleen was grossly enlarged to 29 cm (Figure 2).
There was a mild peritoneal free fluid. CT scan abdomen was consistent with non-obstructive
IHBD dilatation and portal hypertension.

FIGURE 1: Intra hepatic biliary duct was grossly dilated and
cystic (blue arrow) as seen in the computed tomography of the
abdomen
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FIGURE 2: Computed tomography of the abdomen showing
splenic enlargement (blue arrow)

Differential diagnosis included Caroli disease, primary sclerosing cholangitis, primary biliary
cirrhosis, and partial extra-hepatic biliary stricture. Magnetic resonance
cholangiopancreatography (MRCP) was performed, which revealed diffuse hypo density mild
atrophic liver. Portal vein was dilated with multiple collaterals. Peripheral fibrosis, shrunken
right lobe, and enlarged caudate lobe were revealed. The biliary system had massive IHBD
dilatation, CBD dilated up to lower third with abrupt termination or narrowing over the short
segment. Pancreatic duct was normal as seen in Figure 3. There was no intraluminal-filling
defect. The gallbladder was poorly visualized. The spleen was massively enlarged up to 30 cm
and there were dilated tortuous splenic collaterals (Figure 3). There were mild ascites. MRCP
findings were consistent with severe IHBD dilatation, dilated CBD with distal stricture, liver
cirrhosis, portal hypertension, and massive splenomegaly. Upper endoscopy was performed,
which showed esophageal varices of grade II-III.

FIGURE 3: Magnetic resonance cholangiopancreatography
(MRCP) showing dilated portal vein with multiple collaterals
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The patient underwent splenorenal surgical shunt and splenectomy and has been doing well at
a follow up of more than a year till now.

Discussion
Caroli disease results from an arrest in ductal plate remodeling at the level of the larger
intrahepatic bile ducts. In contrast, Caroli syndrome develops when the full spectrum of bile
duct differentiation is affected, such that smaller interlobular ducts are involved and congenital
hepatic fibrosis is seen. Multifocal dilation may either be diffuse, affecting the whole
intrahepatic biliary tree or may be confined to part of the liver [5]. It appears to be inherited in
an autosomal recessive manner. Mutation in PKHD1, the gene linked to adult recessive
polycystic kidney disease (ARPKD), has been identified in patients with Caroli syndrome [34,6].
Caroli syndrome presents a clinical syndrome, which is a combination of Caroli disease (bouts
of cholangitis, hepatolithiasis, and gallbladder stones) and those of congenital hepatic fibrosis
(portal hypertension) [3,5,7]. Clinical progression and presentation of Caroli syndrome is highly
variable, and symptoms may appear early or late during life. Although present from birth, the
disease usually remains asymptomatic during the first 20 years and may also remain so
throughout life. However, when symptomatic, a significant number of these patients present
with a significant loss in their quality of life and their clinical course is frequently worse due to
the repeated episodes of cholangitis with the presence of intrahepatic calculi, intrahepatic
abscesses, and sepsis [6]. The main consequences of congenital hepatic fibrosis are portal
hypertension and the development of esophageal varices, which may result in hematemesis or
melena [7]. In majority of patients, portal hypertension will not be present or will appear only
later in the disease evolution. Bile stagnation and hepatolithiasis explain the recurrent
cholangitis which dominates the clinical course and which is the principal cause of morbidity
and mortality. Complications from Caroli syndrome are chronic abdominal pain, cholangitis,
sepsis, choledocholithiasis, hepatic abscess, cholangiocarcinoma and portal hypertension (SS1)
[7]. Cholangitis carries a poor prognosis with majority of patients dying within 5-10 years. The
major published reports concerning bile ducts cysts have come from Great Britain, France,
Japan and the United States. More than 200 cases of Caroli disease have been reported in
literature and the incidence of Caroli syndrome is more than the pure form of Caroli disease [7].
In addition, various renal disorders may be seen in conjunction with these hepatic diseases,
including autosomal polycystic kidney disease (both dominant and recessive forms), medullary
sponge kidney and medullary cystic disease [8].
Laboratory findings are non-specific. Transaminases may be slightly elevated. The complete
blood count may reveal thrombocytopenia and leucopenia if portal hypertension and
hypersplenism are present. Elevated white blood cell count or ESR may indicate cholangitis.
Blood urea nitrogen (BUN) and creatinine values should be obtained to detect associated renal
disease. Demonstration of communication between sacculi and bile ducts is important in
showing the Caroli disease component of Caroli syndrome, which can be achieved by US, CT
scan, MRCP or endoscopic retrograde cholangiopancreatography (ERCP). Magnetic resonance
imaging can suggest accompanying abnormalities such as portal hypertension, cirrhosis and
renal involvement. Magnetic resonance is the most specific and non-invasive method to depict
the multiple ductal dilatation seen in Caroli disease, called the “lollipop tree”, where cystic
structures of different sizes, shapes and distribution freely communicate with the biliary tree
[9]. ERCP is the gold standard in diagnosis in the case of fusiform dilatations of the biliary
tracts. Congenital hepatic fibrosis is a histopathological diagnosis. The appearance of ductal
dilatation can be confused with polycystic liver disease or obstructive bile duct dilatation [5]. It
is well established that patients with Caroli syndrome suffer from relapsing episodes of
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cholangitis with the possibility of bacteremia and sepsis. It rarely presents in childhood and the
diagnosis is usually made at an advanced age. Although, there are rare case reports published of
even neonatal presentation of the disease [10-11].
In our patient, there were symptoms of the disease since childhood indicated by vomiting of
blood and enlarged spleen but was not diagnosed towards the end of third decade of her life.
The investigations revealed dilatation of intrahepatic bile ducts and huge splenomegaly with
severe thrombocytopenia and severe leucopenia and ascites as prominent findings. This
indicated the presence of portal hypertension most likely from congenital hepatic fibrosis. In
this case, she presented with hematemesis in childhood and blood transfusion at the age 16
years and upper endoscopy proven presence of esophageal varices. All these suggested the
likelihood of Caroli syndrome. After shunt surgery and splenectomy, there was remarkable
hematological improvement. Caroli disease confers an approximately 7% risk of malignancy
[12]. The treatment depends on the clinical features and the location of the biliary abnormality.
When disease is localized to one hepatic lobe, hepatectomy relieves the symptoms and appears
to remove the risk of malignancy. In diffuse Caroli disease, liver transplantation remains the
treatment of choice. The usual complications of Caroli disease/syndrome are cholestasis,
cholangitis, choledocholithiasis and cholangiocarcinoma, which were not found in this patient.

Conclusions
Though infrequently encountered, Caroli syndrome should be considered an important
differential diagnosis in the cases of chronic cholestasis where the exact etiology is
undetermined. Most of the cases reported in the literature are from more affluent countries
rather than developing countries like Tanzania. A higher degree of vigilance is required
amongst physicians, especially in the countries with limited resources, so that sparsely
available and expensive advanced diagnostic modalities can be used more effectively to yield a
timely and accurate diagnosis.
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